Clinical and imaging outcomes of different phenotypes of axial spondyloarthritis: 5-year analysis of the DESIR cohort

Alexandre Sepriano: speaking and/or consulting fees from Abbvie, Novartis, UCB and Lilly. Sofia Ramiro: research grants and/or consultancy fees: AbbVie, Eli Lilly, Galapagos, Janssen, MSD, Novartis, Pfizer, UCB, Sanofi. Désirée van der Heijde: Received consulting fees from AbbVie, Argenx, Bayer, BMS, Galapagos, Gilead, Glaxo-Smith-Kline, Janssen, Lilly, Novartis, Pfizer, Takeda, UCB Pharma and is Director of Imaging Rheumatology bv. Anna Moltó: Received consulting fees from AbbVie, Biogen, BMS,

留言 (0)

沒有登入
gif